Rani Therapeutics Announces Oversubscribed $60.3 Million Private Placement Priced At-the-Market under Nasdaq Rules

Rani Therapeutics Announces Oversubscribed $60.3 Million Private Placement Priced At-the-Market under Nasdaq Rules GlobeNewswire October 17, 2025 Financing led by Samsara BioCapital, L.P. (“Samsara”) with participation from additional investors, including RA Capital Management, Anomaly, Special Situations Funds, Invus and Mr. Mir Imran At the closing of the financing, each of Samsara and Anomaly will have […]

SL Green Realty Corp. Announces Common Stock Dividend

(NYSE:SLG), NEW YORK, Oct. 17, 2025 (GLOBE NEWSWIRE) — SL Green Realty Corp. (NYSE:SLG), Manhattan's largest office landlord, today announced that its board of directors has declared a monthly ordinary dividend of $0.2575 per share of common stock, which is the equivalent of an annualized dividend of $3.09 per share. The dividend is payable in

Libtayo(R) (cemiplimab) Recommended for EU Approval by the CHMP for Adjuvant Treatment of Cutaneous Squamous Cell Carcinoma (CSCC) with a High Risk of Recurrence After Surgery and Radiation

(NASDAQ:REGN), TARRYTOWN, N.Y., Oct. 17, 2025 (GLOBE NEWSWIRE) — Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for Libtayo(R) (cemiplimab) as an adjuvant treatment for adult patients with cutaneous squamous cell carcinoma (CSCC) at high risk of

Blaqclouds Integrates Open-Source DeFi On-Ramp and Off-Ramp Infrastructure Across Ecosystem Including Apollo Wallet, ZEUSxPay and ShopWithCrypto.io

(PinkSheets:BCDS),(Pinksheets:BCDS), ROBESONIA, Pa., Oct. 17, 2025 (GLOBE NEWSWIRE) — Blaqclouds, Inc. (OTC: BCDS), a leading Web3 infrastructure company, today announced the integration of a powerful open-source DeFi on-ramp and off-ramp protocol across its entire ecosystem — including consumer-facing platforms ShopWithCrypto.io, ZEUSxPay.io, and the Apollo Wallet. This integration enables seamless conversion between fiat and crypto using

Rani Therapeutics Announces up to $1.085 Billion Collaboration with Chugai Pharmaceutical Co. for Multiple High-Value Therapeutics Including Rare Disease and Immunology Programs and Announces Concurrent Oversubscribed $60.3 Million Financing

(NasdaqGM:RANI), Rani will receive $10 million upfront payment and is eligible to receive up to $75 million in technology transfer and development milestones, up to $100 million in sales milestones and single digit royalties on product sales for the first license agreement Chugai has the option to extend its rights to partner with Rani on

Exgen Resources and MTB Metals Enter Into Arrangement Agreement to Merge, Creating a Well Funded Copper, Gold and Lithium Exploration and Development Company

(TSX-V:EXG),(OTC US:BXXRF),(Other OTC:BXXRF),(TSX-V:MTB),(Other OTC:MBYMF),(Frankfurt:M9U), VANCOUVER, British Columbia, Oct. 17, 2025 (GLOBE NEWSWIRE) — ExGen Resources Inc. (TSX.V: EXG; OTC: BXXRF) (“ExGen“, the “Company“) and MTB Metals Corp. (TSXV: MTB, OTCQB: MBYMF, Frankfurt: M9U) (“MTB“): ExGen and MTB are pleased to announce that they have entered into an Arrangement Agreement dated October 16, 2025 (the “Arrangement“).

PharmaCorp Rx Inc. Files Final Short Form Base Shelf Prospectus

(TSX-V:PCRX), SASKATOON, Saskatchewan, Oct. 17, 2025 (GLOBE NEWSWIRE) — PHARMACORP RX INC. (“PharmaCorp” or the “Corporation“) (TSXV:PCRX) is pleased to announce that it has filed its Final Short Form Base Shelf Prospectus dated October 14, 2025 (the “Prospectus“) with the securities commissions in each of the provinces of Canada, other than Quebec. The Prospectus allows

StorageVault Finalizes and Receives Additional Expropriation Compensation, and Grows Third Party Management Platform

(TSX:SVI), TORONTO, Oct. 17, 2025 (GLOBE NEWSWIRE) — STORAGEVAULT CANADA INC. (“StorageVault“) (SVI-TSX) is pleased to announce that it has finalized and received proceeds related to the expropriation of one of its properties and that it has added two-third party stores to its third party management platform. StorageVault will record an additional $15 million gain

Achieve Life Sciences Receives FDA Commissioner’s National Priority Voucher for Cytisinicline for Treatment of Nicotine Dependence for E-cigarette or Vaping Cessation

(NASDAQ:ACHV), Potential First-in-Class Treatment for Nicotine E-cigarette or Vaping Cessation Receives Unprecedented Expedited Review Pathway One of Only Nine Therapies Chosen for the FDA's Inaugural National Priority Voucher Program SEATTLE and VANCOUVER, British Columbia, Oct. 17, 2025 (GLOBE NEWSWIRE) — Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global

Prelude Therapeutics Announces Appointment of Katina Dorton, J.D., MBA to its Board of Directors

(NASDAQ:PRLD), WILMINGTON, Del., Oct. 17, 2025 (GLOBE NEWSWIRE) — Prelude Therapeutics Incorporated (Nasdaq: PRLD), a clinical-stage precision oncology company, today announced the appointment of Katina Dorton to its Board of Directors, effective today. Ms. Dorton has more than 30 years of industry expertise and leadership in healthcare and life sciences including service on several boards

Scroll to Top